Broward Health Medical Center First in Florida to Adopt Robotic Ablation Technology to Treat Arrhythmias

The Stereotaxis Genesis Robotic Magnetic Navigation system.

The Stereotaxis Genesis Robotic Magnetic Navigation system.

April 7, 2021 — Stereotaxis announced that Broward Health Medical Center is establishing a robotic electrophysiology (EP) program to expand access to advanced minimally-invasive treatment of heart rhythm disorders in Florida. Broward will be the only hospital in South Florida offering robotic technology to treat patients suffering from arrhythmias and is the first in Florida, and among the first in the nation, to adopt the latest Genesis Robotic Magnetic Navigation system.

“The adoption of this advanced robotic technology further reinforces the commitment Broward Health Medical Center has toward providing high quality cardiac care for patients suffering from all types of arrhythmias,” said Ahmed Osman, M.D., medical director of the cardiac electrophysiology lab. “This technology helps enhance the reach, precision and stability of the traditional tools used in ablation therapy, while having inherent attributes that can increase safety. We are very excited to have access to this technology for our patients.”

Stereotaxis robotic magnetic navigation introduces the benefits of robotic precision and safety to what are often long cardiac ablation procedures.

“On the heels of Broward Health Medical Center’s recent IAC accreditation for electrophysiology, we are excited to bring this latest technology to our complex arrhythmia program,” said Heather Havericak, CEO of Broward Health Medical Center. “Studies suggest that one in four Americans over the age of 40 could develop irregular heartbeats, and over 2.3 million Americans suffer from atrial fibrillation. The adoption of Robotic Magnetic Navigation supports our commitment to providing comprehensive cardiac care for our community and the greater tri-county area.”

“We are delighted to partner with Broward Health to help enhance quality of care and access to therapy for patients in Florida,” said David Fischel, chairman and CEO of Stereotaxis. “We applaud their leadership and look forward to supporting their efforts to build a preeminent heart rhythm program in the region.”

For more information: www.stereotaxis.com